Post by Pharmacosmos Therapeutics Inc.

The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting is an important moment for the oncology community to come together around science, shared learning, and the work still ahead for patients. This year, 30 Pharmacosmos Therapeutics colleagues will be attending across Medical Affairs, MSL, Sales, Market Access, HEOR/RWE, Marketing, Compliance, Clinical Operations, and Advocacy. We’re proud to have a cross-functional team in Chicago listening, learning, and connecting with others who are committed to advancing cancer care. If you're at #ASCO2026, we hope to see you! In attendance: GPO/KAM/IDN/Advocacy Jim Kilgallon; Kristen Butler, MHA; Greg Ferrell, MBA; Scotty Reams, PharmD, MBA; Paul Johnston; Holly Judd, JD; Bruce Simms; Jim Wermes; Orren Taylor FRM Jessica Farrell; Latonya Michelle Calais; Reagan Abney, PACS HEOR/RWE Michael Polson Sales John Kappes; Jennie Bjerke; Joe Stevens Medical Affairs Home Office Karina Utkina, PharmD; Roxanna Monshi, PharmD MSL Dr. Danielle Plummer, PharmD; Ingrid Kalchman, MD; Karan Almaula; Mailey Wilks, DNP, APRN, AGNP-C; John DeOca; Palak Patel, DMSc, PA-C; Dr. Jerrick White Clinical Ops Maggie Gagnon Marketing Kristie Weng; Jordan (Baratta) Luedeke, MBA Compliance Yelena F.; Sandi James #ASCO26 #Oncology #PharmacosmosTherapeutics